A detailed history of Arcus Capital Partners, LLC transactions in Danaher Corp stock. As of the latest transaction made, Arcus Capital Partners, LLC holds 3,135 shares of DHR stock, worth $858,551. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,135
Previous 2,800 11.96%
Holding current value
$858,551
Previous $699,000 12.02%
% of portfolio
0.32%
Previous 0.23%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$235.51 - $267.98 $78,895 - $89,773
335 Added 11.96%
3,135 $783,000
Q1 2024

Apr 19, 2024

BUY
$224.58 - $256.19 $189,770 - $216,480
845 Added 43.22%
2,800 $699,000
Q4 2023

Jan 23, 2024

SELL
$185.1 - $233.13 $236,928 - $298,406
-1,280 Reduced 39.57%
1,955 $452,000
Q3 2023

Oct 16, 2023

BUY
$233.08 - $265.59 $36,360 - $41,432
156 Added 5.07%
3,235 $802,000
Q2 2023

Jul 18, 2023

BUY
$224.99 - $256.14 $692,744 - $788,655
3,079 New
3,079 $738,000
Q4 2022

Jan 27, 2023

SELL
$241.42 - $282.29 $648,454 - $758,230
-2,686 Reduced 61.24%
1,700 $0
Q3 2022

Oct 25, 2022

BUY
$247.06 - $1507.4 $340,448 - $2.08 Million
1,378 Added 45.81%
4,386 $1.13 Million
Q2 2022

Jul 29, 2022

BUY
$237.11 - $299.66 $2,133 - $2,696
9 Added 0.3%
3,008 $763,000
Q1 2022

May 04, 2022

SELL
$257.27 - $315.76 $2,572 - $3,157
-10 Reduced 0.33%
2,999 $880,000
Q4 2021

Jan 28, 2022

BUY
$292.08 - $329.01 $402,778 - $453,704
1,379 Added 84.6%
3,009 $990,000
Q3 2021

Oct 26, 2021

BUY
$272.21 - $332.43 $16,877 - $20,610
62 Added 3.95%
1,630 $496,000
Q2 2021

Aug 11, 2021

BUY
$225.08 - $271.69 $352,925 - $426,009
1,568 New
1,568 $421,000
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $300,305 - $347,702
-1,414 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$212.5 - $245.46 $300,475 - $347,080
1,414 New
1,414 $314,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $199B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Arcus Capital Partners, LLC Portfolio

Follow Arcus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arcus Capital Partners, LLC with notifications on news.